Keyphrases
Acute Kidney Injury
6%
Acute Myocardial Infarction
6%
Adjusted Hazard Ratio
5%
Advanced Hepatocellular Carcinoma
7%
Albumin-bilirubin Grade
10%
All-cause Mortality
6%
Alpha-fetoprotein
8%
Angiogenesis
7%
Antiretroviral Therapy
6%
Arteriovenous Fistula
7%
Barcelona Clinic Liver Cancer
7%
Cancer Cells
8%
Cardiovascular Disease
5%
Cardiovascular Events
8%
Cell Function
7%
Chemotherapy
9%
Chronic Hepatitis B
13%
Chronic Hepatitis B Patients
8%
Chronic Hepatitis C
19%
Chronic Kidney Disease
10%
Chronic Migraine
9%
Cirrhosis
18%
Cirrhotic Patients
6%
Clinical Outcomes
13%
Confidence Interval
33%
Coronary Artery Bypass Grafting
7%
Coronary Artery Disease
5%
COVID-19
7%
Cox Proportional Hazards Model
5%
Direct-acting Antivirals
10%
Endothelial Progenitor Cells
18%
Epithelial-mesenchymal Transition
11%
Estimated Glomerular Filtration Rate
5%
Gag-Pol
6%
Hazard Ratio
23%
Head-and-neck Cancer
14%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
15%
Headache
9%
Hemodialysis Patients
5%
Hepatitis B
6%
Hepatitis B e Antigen (HBeAg)
8%
Hepatitis B Surface Antigen (HBsAg)
13%
Hepatitis B Virus
14%
Hepatitis C
19%
Hepatitis C Virus
23%
Hepatitis C Virus Infection
8%
Hepatocellular Carcinoma
100%
Hepatocellular Carcinoma Patients
20%
Hepatocellular Carcinoma Risk
7%
High Risk
10%
Human Endothelial Progenitor Cells
12%
Human Immunodeficiency Virus Type 1 (HIV-1)
13%
Human Mesenchymal Stem Cells (hMSCs)
14%
Immune Checkpoint Inhibitors
7%
Inflammation
6%
Ischemia
5%
Ischemic Stroke
6%
Liver
7%
Liver Cirrhosis
6%
Macrophages
7%
Major Adverse Cardiovascular Events
6%
MELD Score
5%
Mesenchymal Stem Cells
20%
Mesenchymal Stromal Cells
7%
Meta-analysis
5%
Metastasis
7%
Migraine
17%
Multivariate Analysis
11%
National Cohort Study
12%
Neovascularization
6%
Non-diabetic
5%
Odds Ratio
9%
Oral Tongue Squamous Cell Carcinoma (OTSCC)
7%
Osteogenic Differentiation
7%
Overall Survival
17%
Overexpression
5%
Oxidative Stress
6%
Percutaneous Coronary Intervention
6%
Performance Status
5%
Prognostic Factors
12%
Progression-free Survival
5%
Propensity Score Analysis
6%
Radiofrequency Ablation
10%
Reversible Cerebral Vasoconstriction Syndrome
13%
Risk Factors
16%
Ruptured Abdominal Aortic Aneurysm (rAAA)
11%
Stem Cells
9%
Surgical Resection
9%
Sustained Virological Response
9%
Taipei
7%
Taiwan
54%
Taiwanese
12%
Transarterial Chemoembolization
14%
Treatment Outcome
7%
Tumor
8%
Tumor Necrosis Factor-α
5%
Tumor Recurrence
5%
Type 1 Diabetes Mellitus (T1DM)
6%
Unresectable Hepatocellular Carcinoma
6%
Virus
6%
Medicine and Dentistry
Abdominal Aortic Aneurysm
7%
Acute Kidney Injury
7%
Angiogenesis
6%
Antiviral Drug
6%
Antiviral Therapy
7%
Aortic Dissection
8%
Apoplexy
5%
Arteriovenous Fistula
7%
Bilirubin
12%
Biological Marker
6%
Cancer
6%
Cancer Staging
7%
Cardiovascular Disease
7%
Cardiovascular System
14%
Chronic Hepatitis B
12%
Chronic Hepatitis C
14%
Chronic Kidney Disease
10%
Cohort Analysis
11%
Computer Assisted Tomography
5%
Coronary Artery Bypass Graft
6%
Coronary Artery Disease
13%
Diabetes Mellitus
10%
Diseases
13%
End Stage Renal Disease
5%
Endothelial Progenitor Cell
15%
Endovascular Aneurysm Repair
6%
Fibrosis
6%
Hazard Ratio
18%
Head and Neck Cancer
6%
Head and Neck Squamous Cell Carcinoma
8%
Headache
9%
Hemodialysis
8%
Hepatitis B
7%
Hepatitis B Virus
18%
Hepatitis C
11%
Hepatitis C Virus
16%
Hepatocellular Carcinoma
96%
Immune Checkpoint Inhibitor
5%
Immunotherapy
5%
In Vitro
7%
Infection
10%
Kidney Function
6%
Liver Cancer
9%
Liver Cirrhosis
19%
Liver Disease
5%
Malignant Neoplasm
11%
Mesenchymal Stem Cell
16%
Metastatic Carcinoma
7%
Migraine
11%
Multivariate Analysis
8%
Neoplasm
22%
Odds Ratio
8%
Overall Survival
16%
Percutaneous Coronary Intervention
5%
Platelet
6%
Prevalence
10%
Prognostic Factor
8%
Proportional Hazards Model
9%
Radiofrequency Ablation
8%
Recurrent Disease
9%
Reversible Cerebral Vasoconstriction Syndrome
6%
Squamous Cell Carcinoma
5%
Stem Cell
6%
Stent-Graft
5%
Surgery
17%
Survival Rate
6%
Transcatheter Arterial Chemoembolization
15%